Siemens Healthineers gains FDA clearance for Biograph Vision PET/CT system

Siemens Healthineers announced this week that its Biograph Vision PET/CT imaging system has gained FDA clearance.

Biograph Vision includes new technology that allowed the company to reduce the detector’s lutetium oxyorthosilicate crystal elements from 4-by-4 mm to 3.2-by-3.2 mm, improving its spatial resolution. This helped the system reduce scan time significantly.

Biograph Vision also has a 78-cm bore that can be placed in any location that had previously housed a Biograph PET/CT scanner without making major changes.

“The Biograph Vision represents a major leap in performance beyond any PET/CT system previously manufactured,” Jim Williams, PhD, head of Siemens Healthineers Molecular Imaging, said in a prepared statement. “With this system, we extend the boundaries of PET imaging and help our customers explore a new frontier in precision medicine.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.

And it can do so with almost 100% accuracy as a first reader, according to a new large-scale analysis.

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.